<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is a consensus that both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are associated with a spectrum of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> but the underlying mechanisms are largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>On the other hand, there are ongoing debates about the risk association of insulin use with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We have briefly reviewed recent related research on exploration of risk factors for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and pharmacoepidemiological investigations into drug use in <z:mp ids='MP_0002055'>diabetes</z:mp> on the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, as well as the current understanding of metabolic pathways implicated in intermediary metabolism and cellular growth </plain></SENT>
<SENT sid="3" pm="."><plain>Based on the novel findings from the Hong Kong <z:mp ids='MP_0002055'>Diabetes</z:mp> Registry and consistent experimental evidence, we argue that use of insulin to control <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> is unlikely to contribute to increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk and that dysregulations in the <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-activated protein kinase pathway due to reduced insulin action and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, the insulin-like growth factor-1 (IGF-1)-cholesterol synthesis pathway and renin-angiotensin system, presumably due to <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> and <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, may play causal roles in the increased risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Further exploration into the possible causal relationships between abnormalities of these pathways and the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:mp ids='MP_0002055'>diabetes</z:mp> is warranted </plain></SENT>
</text></document>